Global Markets Direct's, 'AFFiRiS AG - Product Pipeline Review - 2014', provides an overview of the AFFiRiS AG's pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of AFFiRiS AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Full Report Details at
- http://www.fastmr.com/prod/906389_affiris_ag_product_pipeline_review_2014.aspx?afid=101
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
* The report provides brief overview of AFFiRiS AG including business description, key information and facts, and its locations and subsidiaries
* The report reviews current pipeline of AFFiRiS AG's human therapeutic division and enlists all their major and minor projects
* The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
* Special feature on out-licensed and partnered product portfolio
* The report summarizes all the dormant and discontinued pipeline projects
* Latest company statement
* Latest news and deals relating to the AFFiRiS AG's pipeline products
Reasons to Get this Report
* Evaluate AFFiRiS AG's strategic position with total access to detailed information on its product pipeline
* Assess the growth potential of AFFiRiS AG in its therapy areas of focus
* Identify new drug targets and therapeutic classes in the AFFiRiS AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
* Develop strategic initiatives by understanding the focus areas of AFFiRiS AG and exploit collaboration and partnership opportunities
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Plan mergers and acquisitions effectively by identifying the most promising pipeline of AFFiRiS AG
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
* Explore the dormant and discontinued projects of AFFiRiS AG and identify potential opportunities in those areas
* Avoid Intellectual Property Rights related issues
Partial Table of Contents:
Table of Contents
Table of Contents
List of Tables
List of Figures
AFFiRiS AG Snapshot
AFFiRiS AG Overview
Key Information
Key Facts
AFFiRiS AG - Research and Development Overview
Key Therapeutic Areas
AFFiRiS AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
AFFiRiS AG - Pipeline Products Glance
AFFiRiS AG - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
AFFiRiS AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
AFFiRiS AG - Drug Profiles
AD-02
Product Description
Mechanism of Action
R&D Progress
IMMAD-04
Product Description
Mechanism of Action
R&D Progress
ATH-03
Product Description
Mechanism of Action
R&D Progress
PD-01
Product Description
Mechanism of Action
R&D Progress
PD-03
Product Description
Mechanism of Action
R&D Progress
Vaccine for Chronic Kidney Disease
Product Description
Mechanism of Action
R&D Progress
Vaccine for Type 2 Diabetes
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target Angiotensin II for Cardiovascular Diseases
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target PCSK9 for Atherosclerosis
Product Description
Mechanism of Action
R&D Progress
Undisclosed Drug-1
Product Description
Mechanism of Action
R&D Progress
Undisclosed Drug-2
Product Description
Mechanism of Action
R&D Progress
AFFiRiS AG - Pipeline Analysis
AFFiRiS AG - Pipeline Products by Target
AFFiRiS AG - Pipeline Products by Route of Administration
AFFiRiS AG - Pipeline Products by Molecule Type
AFFiRiS AG - Recent Pipeline Updates
AFFiRiS AG - Dormant Projects
AFFiRiS AG - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
AFFiRiS AG, Key Information
AFFiRiS AG, Key Facts
Full Table of Contents is available at:
-- http://www.fastmr.com/prod/906389_affiris_ag_product_pipeline_review_2014.aspx?dt=t&afid=101
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
read full article